Contraline Company
Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam is non-hormonal, designed to last years, and easily reversible.
Investors
(Reupload).png)
(Reupload).png)
Technology:
United States
Industry:
Reproductive Health & Contraception
Headquarters:
Charlottesville, Virginia, United States
Founded Date:
2015-05-20
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
32
Total Funding:
$24,630,000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-11-10
Last Funding Type:
Series A
Register and Claim Ownership